Michaelson Jennifer 4
4 · Cullinan Therapeutics, Inc. · Filed Feb 25, 2026
Insider Transaction Report
Form 4
Michaelson Jennifer
Chief Scientific Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-02-23$13.99/sh−1,752$24,510→ 180,225 total - Sale
Common Stock
[F3]2026-02-24$14.47/sh−3,601$52,106→ 176,624 total
Footnotes (3)
- [F1]Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.68 to $14.31. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact|2026-02-25